ATE83931T1 - Methode fuer die behandlung von viraler gehirnentzuendung. - Google Patents

Methode fuer die behandlung von viraler gehirnentzuendung.

Info

Publication number
ATE83931T1
ATE83931T1 AT88114517T AT88114517T ATE83931T1 AT E83931 T1 ATE83931 T1 AT E83931T1 AT 88114517 T AT88114517 T AT 88114517T AT 88114517 T AT88114517 T AT 88114517T AT E83931 T1 ATE83931 T1 AT E83931T1
Authority
AT
Austria
Prior art keywords
treatment
biologic
viral
cerebral inflammation
vivo subject
Prior art date
Application number
AT88114517T
Other languages
English (en)
Inventor
Robert L Stout
Original Assignee
Clinical Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clinical Biotechnologies Inc filed Critical Clinical Biotechnologies Inc
Application granted granted Critical
Publication of ATE83931T1 publication Critical patent/ATE83931T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT88114517T 1987-09-22 1988-09-06 Methode fuer die behandlung von viraler gehirnentzuendung. ATE83931T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9953187A 1987-09-22 1987-09-22
EP88114517A EP0308717B1 (de) 1987-09-22 1988-09-06 Methode für die Behandlung von viraler Gehirnentzündung

Publications (1)

Publication Number Publication Date
ATE83931T1 true ATE83931T1 (de) 1993-01-15

Family

ID=22275455

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88114517T ATE83931T1 (de) 1987-09-22 1988-09-06 Methode fuer die behandlung von viraler gehirnentzuendung.

Country Status (3)

Country Link
EP (1) EP0308717B1 (de)
AT (1) ATE83931T1 (de)
DE (1) DE3877102T2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599558A (en) * 1989-09-15 1997-02-04 Curative Technologies, Inc. Selecting amounts of platelet releasate for efficacious treatment of tissue
IL95641A0 (en) * 1989-09-15 1991-06-30 Curative Tech Inc Preparation of a platelet releasate product

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4572834A (en) * 1984-04-10 1986-02-25 Clinical Reference Laboratory, Inc. Biologic and method of preparing same

Also Published As

Publication number Publication date
DE3877102D1 (de) 1993-02-11
EP0308717A2 (de) 1989-03-29
DE3877102T2 (de) 1993-07-15
EP0308717B1 (de) 1992-12-30
EP0308717A3 (en) 1990-02-14

Similar Documents

Publication Publication Date Title
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
EP0199479A3 (en) Ozone decontamination of blood and blood products
ATE183087T1 (de) Verwendung von beta-hydroxy-beta- methylbutyratsäuere zur förderung der stickstoffzurückhaltung beim menschen
ATE130762T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
SE8703625D0 (sv) New medical use
CA2092905A1 (en) Treatment of autoimmune diseases by oral administration of autoantigens
ZA878877B (en) Treatment of diseases caused by viruses
ES8507567A1 (es) Metodo para estabilizar un concentrado de gamma globulina
ATE135914T1 (de) Aica riboside zur prophylaktischen behandlung von krankheiten mit einer verminderten durchblutung.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ATE83931T1 (de) Methode fuer die behandlung von viraler gehirnentzuendung.
ES8205190A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10-14-hexadecapentaenoico.
DE69428797D1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
Majkowski et al. EEG and clinical studies of the development of alumina cream epileptic focus in split‐brain cats
AU1162788A (en) Oxime-ethers of 2,6-dioxobicyclo-(3.3.0)octanones for treatment of heart and circulation diseases
SU1069818A1 (ru) Способ профилактики гриппа
宋宝珠 et al. SHORT-TERM EFFECT IN 135 CASES OF ENURESIS TREATED BY WRIST-ANKLE NEEDLING
Valdimarsdottir The effects of relaxation training and experimental stressors on the immune system.
RU94002713A (ru) Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда)
Mutoh Effect of postnatal anoxia on seizure susceptibility in rats: bicuculline-induced seizures and pretreatment with iproniazid
Machacek et al. NEW YORK DERMATOLOGICAL SOCIETY
GEU1997134Y (en) Biodonor
ATE76302T1 (de) Verwendung von einer immunstimulanten biologisten substanz zur herstellung eines medikaments zur behandlung des menschlichen immunschwaechevirus.
UA18517A (uk) Спосіб визhачеhhя міhімальhої кількості сеаhсів рефлексотерапії

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties